Ramesh Kumar
Director/Board Member bij OCUGEN, INC.
Vermogen: - $ op 31-03-2024
Profiel
Ramesh Kumar was the founder of Traws Pharma, Inc. (founded in 1998) where he served as the Chief Executive Officer & Director from 2018 to 2019.
Currently, he holds the position of Independent Director at Ocugen, Inc. since 2019 and Director at Ocugen OpCo, Inc. since 2019.
In the past, he worked as a Director at Nextran, a Scientist at Bristol Myers Squibb Co., and as the President-Genomics & Transgenics Division at Kimeragen, Inc. He also held positions as a Principal at Princeton University and the National Cancer Institute.
Dr. Kumar obtained a doctorate degree from the University of Illinois and completed his undergraduate and graduate studies at Panjab University Chandigarh.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
OCUGEN INC
-.--% | 09-06-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Ramesh Kumar
| Bedrijven | Functie | Begin |
|---|---|---|
| OCUGEN, INC. | Director/Board Member | 27-09-2019 |
| Ocugen OpCo, Inc. | Director/Board Member | 01-06-2019 |
Eerdere bekende functies van Ramesh Kumar
| Bedrijven | Functie | Einde |
|---|---|---|
| TRAWS PHARMA, INC. | Founder | 15-01-2019 |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | - |
Nextran
 Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The private company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Director/Board Member | - |
| Kimeragen, Inc. | Corporate Officer/Principal | - |
| Princeton University | Corporate Officer/Principal | - |
Opleiding van Ramesh Kumar
| University of Illinois | Doctorate Degree |
| Panjab University Chandigarh | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| TRAWS PHARMA, INC. | Health Technology |
| OCUGEN, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
| Kimeragen, Inc. | Commercial Services |
Nextran
Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The private company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Health Technology |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
| Ocugen OpCo, Inc. |
